Nanotechnology holds great promise in the quest for better computers, electronics, medicine, medical devices, biomaterials and energy production. But like all new technologies, it also raises questions, such as the potential toxicity and environmental impact of nanomaterials and regulatory approval challenges.
Regulatory organizations in the US and across the world have concluded that nanoparticles present an entirely new risk that requires analysis, study and regulatory oversight. As a U.S. delegate on the International Organization for Standardization (ISO) Technical Committee on Nanotechnologies, Dr. Pleus is developing environmental health and safety (EHS) standards for nanomaterials and is assisting in the evaluation of EHS risks from exposure to engineered nanoparticles. He is co-founder of the 2009 Nanotechnology Health and Safety Forum that focused on the role of corporations, government and non-profits in the future of nanotechnology.
Intertox is considered a global leader in nanotechnology risk assessment and is assisting companies and organizations around the world with product-related nanotechnology issues, including regulatory approval.